7-21900080-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001277115.2(DNAH11):​c.13263G>C​(p.Pro4421Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,613,828 control chromosomes in the GnomAD database, including 166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P4421P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.010 ( 22 hom., cov: 33)
Exomes 𝑓: 0.011 ( 144 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.82

Publications

2 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 7-21900080-G-C is Benign according to our data. Variant chr7-21900080-G-C is described in ClinVar as Benign. ClinVar VariationId is 163129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.82 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (1594/152240) while in subpopulation NFE AF = 0.0139 (945/68020). AF 95% confidence interval is 0.0132. There are 22 homozygotes in GnomAd4. There are 853 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.13263G>C p.Pro4421Pro synonymous_variant Exon 81 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.13263G>C p.Pro4421Pro synonymous_variant Exon 81 of 82 5 NM_001277115.2 ENSP00000475939.1
DNAH11ENST00000479878.1 linkn.634G>C non_coding_transcript_exon_variant Exon 4 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1594
AN:
152122
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00225
Gnomad AMI
AF:
0.00659
Gnomad AMR
AF:
0.00740
Gnomad ASJ
AF:
0.00577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0377
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.0110
AC:
2734
AN:
249016
AF XY:
0.0107
show subpopulations
Gnomad AFR exome
AF:
0.00175
Gnomad AMR exome
AF:
0.00449
Gnomad ASJ exome
AF:
0.00736
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0381
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.0126
GnomAD4 exome
AF:
0.0113
AC:
16548
AN:
1461588
Hom.:
144
Cov.:
31
AF XY:
0.0112
AC XY:
8115
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.00134
AC:
45
AN:
33478
American (AMR)
AF:
0.00470
AC:
210
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00712
AC:
186
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000359
AC:
31
AN:
86244
European-Finnish (FIN)
AF:
0.0363
AC:
1940
AN:
53386
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
0.0122
AC:
13517
AN:
1111794
Other (OTH)
AF:
0.00996
AC:
601
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
853
1705
2558
3410
4263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1594
AN:
152240
Hom.:
22
Cov.:
33
AF XY:
0.0115
AC XY:
853
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41546
American (AMR)
AF:
0.00739
AC:
113
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00577
AC:
20
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.0377
AC:
399
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0139
AC:
945
AN:
68020
Other (OTH)
AF:
0.00664
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
16
Bravo
AF:
0.00776
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0104
EpiControl
AF:
0.00961

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro4421Pro in exon 81 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 1.2% (101/8216) o f European American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs72658834).

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 7 Benign:1
Oct 20, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAH11: BP4, BP7, BS1, BS2

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.0
DANN
Benign
0.63
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72658834; hg19: chr7-21939698; API